Cheapest Tirzepatide Providers in 2026 — Ranked & Reviewed

Tirzepatide is the most effective GLP-1 weight loss medication, but retail prices can hit $1,000+/month. We ranked every legitimate telehealth provider offering tirzepatide by their lowest published monthly cost for 2026 — so you can find a real, affordable option without falling for hidden-fee pricing.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

How we rank & what counts as “legit”

Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.

Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].

Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Quick Picks: Top 5

#ProviderScore
1Enhance MD8.6Visit
2Telos Rx8.2Visit
3YourEra7.1Visit
4Trimi Health7.7Visit
5Found7.6Visit

Detailed Reviews

1

Enhance MD

Verified partner

Best for: lab-monitored compounded GLP-1 with mandatory video visit

8.6

Enhance MD pairs compounded semaglutide and tirzepatide with mandatory baseline metabolic labs at Quest Diagnostics and a synchronous video visit with a board-certified clinician — a more rigorous onboarding than the async-only compounded GLP-1 model most telehealth providers use. Three tiers (Core semaglutide, Advanced tirzepatide, Elite combined) plus aggressive intro pricing ($49 first month on Core).

Score Breakdown

Value25%
8.5
Effectiveness25%
8.5
User Experience15%
8.5
Trust & Safety15%
8.5
Accessibility10%
9
Support10%
9

Pros

  • Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
  • Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
  • Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
  • Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
  • Low first-month intro pricing: $49 Core, $99 Advanced, $189 Elite
  • Unlimited clinician messaging and dose-adjustment support included

Cons

  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
  • Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
  • No insurance accepted — cash pay, HSA/FSA eligible
  • Intro pricing resets to full tier rate after 30 days — the $49/$99/$189 figures aren't ongoing cost
2

Telos Rx

Verified partner

Best for: Needle-free and microdosed compounded GLP-1 options with lab-monitored care

8.2

Telos Rx is a compounded telehealth platform (Superior Health Solutions LLC) offering GLP-1 weight loss alongside longevity, recovery, and sexual-health peptides. Its GLP-1 line includes compounded semaglutide and tirzepatide injections plus needle-free sublingual and microdosed tirzepatide, with provider dose adjustments, lab monitoring, free discreet shipping, FSA/HSA, and cancel-anytime. Headline prices are first-month intro rates (from $49); ongoing cost is higher. Compounded meds are not FDA-approved; pharmacy and states unpublished; no LegitScript shown.

Score Breakdown

Value25%
8
Effectiveness25%
8.5
User Experience15%
8.5
Trust & Safety15%
7.5
Accessibility10%
8.5
Support10%
8.5

Pros

  • Multiple GLP-1 modalities: compounded semaglutide and tirzepatide injections plus needle-free sublingual and microdosed tirzepatide
  • Provider-led dose adjustments and lab monitoring as your protocol changes
  • Free discreet, temperature-controlled shipping (no Telos branding on the outside)
  • FSA/HSA eligible and cancel anytime in one click
  • Trustpilot rating of 4.9; full compliance suite published (Privacy, Terms, HIPAA, Shipping & returns)
  • Integrated care team spanning weight loss, longevity, recovery, and sexual health (peptide-led)

Cons

  • Headline pricing is 'first month low as' intro pricing (semaglutide $49, tirzepatide $99) — ongoing monthly cost is higher and shown during intake
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Compounding pharmacy partner is not named
  • State-availability list is not published
  • No LegitScript certification displayed
3

YourEra

Verified partner

Best for: $99 first-month entry pricing on compounded GLP-1s

7.1

YourEra is a LegitScript-certified telehealth platform offering compounded semaglutide and tirzepatide injections starting at $99 for the first month, with ongoing pricing set after the medical intake. Care runs entirely online, with doctor visits and prescriptions handled remotely. The site is upfront that these compounded medications are not the brand-name drugs Ozempic, Wegovy, Mounjaro, or Zepbound — a candid bit of transparency for the category.

Score Breakdown

Value25%
7.5
Effectiveness25%
7
User Experience15%
7
Trust & Safety15%
6.5
Accessibility10%
7
Support10%
7

Pros

  • $99 first-month entry pricing for compounded GLP-1 — among the cheapest in the market
  • LegitScript Certified
  • Clearly states it's 100% online doctor visits and prescriptions
  • Honest that the compounded medications aren't brand-name Ozempic, Wegovy, Mounjaro, or Zepbound

Cons

  • Ongoing maintenance-dose price isn't published — ask before committing
  • Legal entity name and state of incorporation aren't disclosed
  • Pharmacy partners not named — only "state-licensed pharmacies"
  • Per-state availability not listed; verify your state ships before buying
  • Initial consultation fee not disclosed
  • Lab work and ongoing-care details aren't spelled out
4

Trimi Health

Verified partner

Best for: budget-conscious shoppers

7.7

Telehealth provider offering some of the lowest compounded GLP-1 pricing available.

Score Breakdown

Value25%
9
Effectiveness25%
7.5
User Experience15%
7
Trust & Safety15%
7
Accessibility10%
7.5
Support10%
7

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Cons

  • Limited public information on program details
5

Found

Verified partner

Best for: mainstream telehealth GLP-1 access

7.6

Personalized weight care platform with a self-pay membership model plus medication costs.

Score Breakdown

Value25%
8.5
Effectiveness25%
7.5
User Experience15%
7
Trust & Safety15%
7
Accessibility10%
7.5
Support10%
7

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Cons

  • Limited public information on program details

Frequently Asked Questions

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)Internal Revenue Service.